Диклоген

Quick links to important sections

Диклоген

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Диклоген

Quick Facts

Property Description
Active ingredient Diclofenac sodium (Диклофенак натрия)
Form Topical gel or solution
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common use Local relief of pain and inflammation
Origin Synthetic, Phenylacetic acid derivative

1. Identity as a Nonsteroidal Anti-inflammatory Drug

Диклоген is a medicinal product whose active substance is Diclofenac sodium, chemically classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). This compound is a synthetic agent derived from phenylacetic acid. The NSAID classification is globally recognized, and the use of topical diclofenac is indicated for managing localized musculoskeletal inflammation. While Diclofenac sodium is the core component, Диклоген is often characterized as a topical kit or a specific gel formulation, differentiating it from other Diclofenac delivery systems.


2. Form, Composition, and General Purpose

Диклоген is typically presented as a topical dosage form, such as a gel or solution, intended for local dermal application, which is its defining route of delivery. The core composition involves the active ingredient integrated into an aqueous or hydroalcoholic base that is optimized for absorption. The general therapeutic purpose is to provide highly targeted relief from discomfort, stiffness, and inflammation, for example, relieving localized tenderness associated with tendon conditions. Topical Diclofenac is characterized by specific delivery benefits. Furthermore, Диклоген is frequently a combination product, where Diclofenac is supplemented with rubefacients like menthol or camphor to enhance local peripheral pain relief, which is a key characteristic distinguishing it from single-ingredient formulations.

Regulatory References

  1. NIH DailyMed Monograph

What side effects are possible with Диклоген?

Possible side effects and safety information

The official safety information for Diclofenac, the active substance in Диклоген, is structured to address both local application-site reactions and the systemic risks associated with the Nonsteroidal Anti-inflammatory Drug (NSAID) class.


Adverse Reaction Scope

The most frequently documented effects are Common (1% to 10%) local reactions, which are classified as Skin and Subcutaneous Tissue Disorders. These typically include application-site dermatitis, pruritus (itching), erythema (redness), and a burning sensation. Rare but serious reactions are also documented across several System-Organ Classes.

System-Organ Class Serious Adverse Reactions (Label-Documented)
Cardiovascular Disorders Increased risk of serious thrombotic events (myocardial infarction, stroke).
Gastrointestinal Disorders Risk of bleeding, ulceration, and perforation.
Immune System Disorders Severe skin adverse reactions (e.g., Stevens-Johnson Syndrome) and anaphylactic reactions.

Regulatory Safety Considerations

The safety profile includes specific limitations. Time-related safety patterns indicate that the risk of serious cardiovascular and gastrointestinal events increases with longer treatment duration. Safety-related restrictions include a contraindication for use in the perioperative setting of Coronary Artery Bypass Graft (CABG) surgery and a warning against application to non-intact or damaged skin.

Population-Specific Safety Considerations are explicit in official labeling. For example, use is contraindicated in late-stage pregnancy (starting at 30 weeks gestation) due to the risk of premature closure of the fetal ductus arteriosus. Additionally, older adults are documented as being at greater risk for serious adverse gastrointestinal and cardiovascular events.

This regulatory structure ensures that while the product is administered topically, the potential for systemic NSAID class effects is clearly communicated.

Overdose and Emergency Response

The official regulatory profile for Диклоген (Diclofenac sodium topical) notes that overdose is generally considered unlikely due to the low systemic absorption when the product is used topically as directed. However, the regulatory documentation addresses the potential for significant systemic effects should the gel or solution be subject to accidental oral ingestion.

Manifestations following such systemic exposure primarily align with established NSAID toxicity. Officially documented complications include acute renal failure, convulsions (seizures), respiratory depression, and severe gastrointestinal irritation. Life-threatening outcomes such as anaphylactic reactions and severe dermatological events are explicitly listed as risks requiring urgent intervention. Furthermore, the label notes that patients who are elderly or have pre-existing renal or hepatic impairment face the greatest risk for severe NSAID-related complications.

In the event of suspected overdose or accidental ingestion, immediate medical attention must be sought. Regulator-described management includes symptomatic and supportive treatment for complications. For accidental oral ingestion, procedures such as gastric lavage or inducing vomiting may be considered. It is officially stated that no specific antidote is known for Diclofenac overdose. Additionally, stop use immediately upon the first sign of a rash or any indication of hypersensitivity.

Therapeutic Uses of Диклоген

Quick Facts

  • Usage: Helps manage acute and chronic discomfort.
  • Arthritis: Used to address the symptoms of joint conditions such as osteoarthritis and rheumatoid arthritis.
  • General Pain: Utilized to provide relief for mild to moderate pain, including certain types of headaches.

What Диклоген Treats: Main Uses and Benefits

Диклоген is a formulation containing diclofenac, which is generally used to help manage symptoms associated with certain painful and inflammatory conditions. The therapeutic goal is to help reduce discomfort and swelling in affected areas.

This product is indicated for the symptomatic management of chronic joint conditions, including osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It may be used to address related signs and symptoms such as joint stiffness and tenderness to support improved function.

It is also utilized for the relief of mild to moderate acute pain from various sources. Examples include managing pain associated with menstrual periods (primary dysmenorrhea) and providing relief for certain acute migraine attacks.

The use of this medication is part of an overall treatment plan intended to contribute to the patient's comfort and support the maintenance of everyday mobility.

Eligibility and Restrictions for Use

Диклоген, containing the active substance diclofenac, is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation. Most healthy adults can typically use diclofenac, but its suitability depends on individual health conditions and history. Always consult a healthcare professional to determine if this medication is appropriate for you.

Contraindications (Who Cannot Use Diclofenac)

Diclofenac is generally contraindicated (should not be used) in patients with the following conditions:

Condition
Allergy to diclofenac, aspirin, or any other NSAID, including a history of asthma, hives, or allergic-type reactions after taking these medications.
Active gastrointestinal bleeding or peptic ulcer disease.
Severe or established heart conditions, such as heart failure (NYHA Class II-IV), established ischemic heart disease, peripheral arterial disease, or cerebrovascular disease.
Recent heart bypass surgery (Coronary Artery Bypass Graft or CABG).
Pregnancy after 20 weeks gestation, as it may cause fetal kidney problems or premature closure of the fetal ductus arteriosus.

Precautions (Use with Caution)

Careful medical consideration is required for individuals with: a history of stomach ulcers or bleeding, high blood pressure, fluid retention (edema), liver or kidney impairment, or significant risk factors for cardiovascular events (e.g., smoking, diabetes, high cholesterol). Use in children varies by formulation and indication; it is not approved for all pediatric age groups or uses. The lowest effective dose for the shortest duration is recommended for all patients, especially those with increased risks.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Diclogen (Diclofenac) is primarily defined by documented effects on platelet function, prostaglandin synthesis, and drug clearance.

Contraindicated and High-Risk Combinations

Concurrent use with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including aspirin, is not recommended due to a significantly increased risk of serious gastrointestinal adverse events. Use is also contraindicated in the setting of peri-operative pain for Coronary Artery Bypass Graft (CABG) surgery.

Clinically Significant Interactions

Co-administration with anticoagulants, antiplatelets, or corticosteroids requires careful monitoring as it increases the risk of bleeding and gastrointestinal damage due to additive pharmacodynamic effects. Diclogen can increase the plasma concentrations of certain medicines, including Lithium, Digoxin, and Methotrexate, by reducing their renal clearance, potentially leading to toxicity. Conversely, strong inhibitors of the CYP2C9 enzyme, such as Voriconazole, may increase Diclogen's systemic exposure.

Food and Timing

Taking Diclogen with alcohol increases the risk of severe gastrointestinal bleeding. Specific oral formulations may require administration on an empty stomach to ensure proper absorption. Elderly patients face a higher risk for adverse outcomes associated with these interactions.

Mechanism of Action

Primary Action: Cyclooxygenase (COX) Enzyme Inhibition

This mechanism involves the diclofenac component acting as a non-selective inhibitor of the COX-1 and COX-2 enzymes. This interaction reduces the conversion of arachidonic acid into prostanoids, primarily Prostaglandin E2 ( PGE2), thereby modifying the systemic inflammation cascade. This molecular action results in a decrease in PGE2-mediated tissue sensitization and localized vascular changes.

Dual Modulation of Pain Signaling

The drug modulates the nociceptive pathway through both peripheral and central channels. Peripheral action, primarily by diclofenac, reduces sensitization at the injury site. Central action, primarily by paracetamol, involves inhibiting prostaglandin synthesis in the brain. This combined approach modifies pain transmission at both the source and the processing center, resulting in a decrease in the overall transmission of afferent pain signals.

Regulation of Hypothalamic Thermostat

The paracetamol component's central mechanism targets the hypothalamus, where it inhibits PGE2 synthesis. This action reduces the concentration of pyrogens, which modifies the abnormally elevated temperature set-point regulated by the brain. This mechanism triggers the body's cooling processes, leading to the lowering of the elevated hypothalamic set-point.

Dosage and Administration Information

How to Use Diclofenac Sodium Topical Formulations

Administration of Diclofenac sodium topical formulations, such as gels or solutions, is strictly limited to dermal application onto the affected area. The overarching principle for use is to administer the lowest effective dosage for the shortest necessary duration.


Dosing Regimens and Frequency

Dosing schedules depend on the specific formulation and site of use.

Formulation/Strength Target Joint Area Single Dose and Frequency Max Daily Dose
Topical Gel, 1% Lower Extremity 4 grams, four times daily (QID) 32 grams total
Topical Gel, 1% Upper Extremity 2 grams, four times daily (QID) 32 grams total
Topical Solution, 2% Knee 40 mg (2 pump actuations), two times daily (BID) Not specified

Application Procedures and Constraints

Accurate dosing requires the use of the dosing card supplied with the 1% gel or priming the pump before the first use of the 2% solution. The product must be gently massaged into clean, dry, intact skin covering the entire joint.

Specific constraints govern post-application activities to ensure proper use:

  • Hand Hygiene: Hands must be washed completely after application, unless the hands themselves are the area being treated.
  • Occlusion and Heat: External heat or occlusive dressings (e.g., bandages) must not be applied to the treated area.
  • Water Exposure: Showering or bathing should be avoided for at least one hour after applying the gel or 30 minutes for the solution formulation.

Population Considerations

The safety and effectiveness of these topical products are not established for use in pediatric patients (under 18 years of age). For older adults, dosing should generally begin at the lower end of the dosing range.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research on Combination Therapy in Chronic Pain Management

Research on the combination of Drug A (Diclofenac) and Drug B (Thiocolchicoside) has been the subject of research exploring its use in populations with chronic pain. The studies primarily focused on individuals managing moderate to severe chronic musculoskeletal pain, such as low back pain.

  • Studies evaluated whether this approach was associated with changes in symptom duration and intensity compared to placebo or monotherapy.
  • Researchers have examined whether there is an association between this combination and measures of quality of life compared to monotherapy. Findings were mixed across different study populations.

Evaluation Measures

The approach was evaluated in studies to determine whether it resulted in a difference in efficacy measures. Clinical trials focused on changes in pain and functional status.

Studies examined endpoints related to pain intensity and functional status. These studies typically utilized standardized tools such as the Visual Analogue Scale (VAS) to measure pain and the Oswestry Disability Index (ODI) to assess functional improvement.

Study Limitations and Research Scope

The majority of published studies available for review are Phase II trials with limited sample sizes. Evidence remains limited regarding the long-term changes associated with this combination therapy over periods exceeding 12 months.

Specific research evaluated tolerability in certain subgroups. The initial research studies enrolled healthy adult participants to assess the scope of potential events. The research available does not currently allow for a definitive comparison of event profiles relative to individual drug administration.

Frequently Asked Questions (FAQ)

Common questions about Диклоген (FAQ)

Q: Is Диклоген the same type of medicine as ibuprofen?

Диклоген's active ingredient is diclofenac, and like ibuprofen, it is classified as a non-steroidal anti-inflammatory drug (NSAID). Official sources note that both substances work by reducing certain enzymes in the body to help relieve pain and inflammation.


Q: How quickly does Диклоген start working after you take it?

The time it takes for relief to start depends on the form of the medicine. According to official product information, oral forms may begin working within 30 minutes. For topical gels applied to the skin, it can take one to two days to feel the full pain-relieving effects.


Q: How long does the effect of Диклоген last in the body?

The duration of effect varies, although the active substance has a short half-life of around one to two hours. The pain relief provided by some forms can last up to eight hours, and official information indicates that effects from the topical gel may persist for one to two days after the application stops.


Q: Can you take Диклоген if you are already taking a blood thinner?

Regulatory documents state that using diclofenac with anticoagulants (commonly called blood thinners) requires careful monitoring. This combination can significantly increase the risk of bleeding and gastrointestinal damage.


Q: What are the most common reasons a doctor prescribes Диклоген?

According to official prescribing information, the most common prescribed use for topical diclofenac is to provide local relief for the pain and inflammation associated with osteoarthritis. This use is targeted for joints that can be easily treated on the skin surface, such as the knees, ankles, and hands.


Q: Is Диклоген available without a prescription in some countries?

The legal status of the medicine changes depending on the country and the specific formulation. While many oral forms of diclofenac are prescription-only, certain low-dose topical gels are available without a prescription for short-term use in various regions.


Q: Does taking Диклоген affect driving or operating machinery?

Regulatory documents indicate that diclofenac may cause central nervous system side effects, such as dizziness or drowsiness, in some users. Patients who experience these types of reactions are cautioned regarding their ability to drive or operate hazardous machinery.


Q: Are there any long-term effects of using Диклоген?

Official safety warnings indicate that the risk of serious side effects, particularly cardiovascular (heart-related) and gastrointestinal (stomach-related) events, increases with longer treatment duration. Official safety information emphasizes that the risk of adverse events is associated with longer treatment duration.


Q: What is the difference between Диклоген and diclofenac?

Diclofenac is the name of the active drug substance itself, which belongs to the NSAID class of medicines. Диклоген (or Diclogen) is a specific brand name or combination product sold that contains diclofenac sodium as its core ingredient.


Q: Is it possible for Диклоген to cause drowsiness?

Official product information lists drowsiness as a documented undesirable effect that may occur while using diclofenac.


Q: Are there any foods that interact with Диклоген?

While the topical gel has no specific food restrictions, oral formulations may have specific administration requirements, such as taking them on an empty stomach to ensure proper absorption.


Q: Is it necessary to take Диклоген with food?

For topical forms (gel or solution), food requirements do not apply. For certain oral forms (like enteric-coated tablets), the product label notes that administration with food or milk is sometimes specified to minimize stomach upset, while others may require an empty stomach for proper action.


Q: Why do some forms of Диклоген need to be swallowed whole?

Some diclofenac tablets are manufactured with an enteric coating or as extended-release forms. Official labeling for these forms specifies that they should be swallowed whole. This is necessary because the coating or design prevents the active ingredient from being released too early in the stomach, which could compromise the medicine's intended action or increase the risk of stomach side effects.


Q: Is it normal to feel a change in appetite while using Диклоген?

Official safety documents list a decrease or change in appetite as an uncommon or rare side effect. This has been documented as being associated with the use of diclofenac, and in some cases, it may be a symptom related to effects on the liver.


Q: Does Диклоген interact with common supplements like multivitamins?

Regulatory warnings generally caution against combining diclofenac with other medications, including herbal remedies and dietary supplements, as official safety data on these specific interactions is often not available.


Q: What does official research say about the use of Диклоген for arthritis?

Clinical trials support the use of diclofenac for joint pain, and the topical gel formulation is specifically indicated for treating the pain of osteoarthritis in certain joints. Regulatory documents confirm its use for localized pain and inflammation.


Q: What are the signs of a severe allergic reaction to Диклоген?

According to official documents, signs of a serious allergic reaction, such as anaphylaxis, may include sudden swelling of the face, lips, throat, or tongue, a widespread skin rash (hives), or difficulty breathing. Official documents advise that severe reactions like anaphylaxis require emergency medical care if those signs are observed.


Q: Can Диклоген be used for a fever?

As an NSAID, diclofenac does have fever-reducing properties. However, its use for fever can mask the signs of inflammation and infection, and the primary approved indications are typically for pain and inflammation.


Q: Is it true that Диклоген is absorbed faster in a patch or gel form?

Official pharmacokinetic studies indicate that the rate of absorption is significantly different between forms. Maximum drug levels in the bloodstream are reached much faster after taking an oral tablet than after applying a topical gel, where absorption into the system is generally slower.


Q: What is the half-life of Диклоген in the body?

Official regulatory pharmacokinetics data states that the terminal half-life of unchanged diclofenac in the body is approximately one to two hours.


Q: Can Диклоген cause skin sensitivity to the sun?

Official product labels warn that diclofenac may cause the skin to become more sensitive to sunlight (photosensitivity). Because of this risk, official labeling recommends protection from sun exposure, including artificial sources like tanning beds, during treatment.


Q: Is it common for people to have side effects when starting Диклоген?

Yes, for the topical gel, local skin reactions at the application site are the most frequently documented side effects, occurring in 1% to 10% of users. These reactions, such as redness, itching, or rash, are typically observed early in the course of treatment.

How should Диклоген be stored and disposed of?

How to Store and Dispose of Diclogen (Diclofenac)

Official regulatory documents define strict requirements for storing and disposing of this medicine to maintain its stability and ensure environmental safety.

Storage Requirements

  • Temperature Control: Store the medicine at room temperature, typically not exceeding 25 C or 30 C (check specific label). Protect the product from exposure to heat and ignition sources.
  • Environmental Protection: Keep Diclogen in a dry place and protect from light by storing it in its original, tightly closed container.
  • Child Safety: It is mandatory to keep the medicine out of the reach of children (store locked up).

Disposal Requirements

  • Official Disposal: Dispose of unused or expired medicine and its container in accordance with all local, regional, and national regulations.
  • Environmental Protection: Do not dispose of Diclogen by flushing it down a toilet or pouring it into a drain. It must not be released into sewers, surface water, or ground water.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Диклоген found in:

A-Z Index: